NOVEMBER 2023LIFE SCIENCES REVIEW6Pharmaceutical companies are increasingly turning to outsourced bioanalytical testing to meet the surging demand in drug development. This shift has led to a substantial rise in the revenue of the Global Bioanalytical Testing Services market. The sector is experiencing a boost from heightened research and development investments, particularly in the pharmaceutical and biopharmaceutical industries. These investments are driving the need for bioanalytical services to support drug discovery and development. The adoption of point-of-care diagnostics and increased healthcare expenditure worldwide further contribute to the industry's growth.The Global Bioanalytical Services Market is set to reach approximately $2 bn by 2028 with a strong CAGR of about 9 percent from 2022 to 2029. This growth is driven by significant technological advances that have made bioanalytical services indispensable across various industries. Biotechnology has empowered the engineering of biological molecules for medical applications, resulting in transformative developments such as recombinant hormones, monoclonal antibodies, and vaccines. Advanced techniques like mass spectrometry, liquid chromatography, and next-generation sequencing have significantly improved sensitivity and specificity in bioanalysis. Emerging trends include device miniaturization, automation, artificial intelligence, and omics data integration, promising to advance our understanding of biological systems.This Life Sciences Review APAC edition brings readers the key developments in bioanalytical services through thought leadership articles from NarayanaRao, Vice President of Biopharma, Asia Pacific Middle-East Africa, Avantor, and Jessica Thongcharen, Director Global Patient Safety & Evaluation- Clinical Operations, Takeda.Narayana Rao explores the rapid growth of the global cell and gene therapy (CGT) market, driven by biomanufacturing innovations, challenges in scaling CGT processes, and solutions to overcome these challenges. Jessica Thongcharen discusses the need for improved measurement and evaluation in healthcare access initiatives, particularly in low- and middle-income countries.In this edition featuring the Top Bioanalytical Services Providers in APAC 2023, we hope you find the right partner suited to your business requirements.Let us know your thoughts.EDITORIALThe Bioanalytical Revolution in Drug DevelopmentCopyright © 2023 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.Editorial StaffAaron PierceCarolynn WaltersShirley FaithRussell ThomasGilbert HooverAncel CastelinoDisclaimer: *Some of the Insights are based on our interviews with CIOs and CXOsJeremy WilliamsManaging Editoreditor@lifesciencesreview.comManaging EditorJeremy WilliamsDecember - 01 - 2023, Vol 04, Issue - 52 ( ISSN 2831-8331) Published by ValleyMedia, Inc.To subscribe to Life Sciences ReviewVisit www.lifesciencesreview.com VisualizersRonald DonovanKevin Parker Email:sales@lifesciencesreview.comeditor@lifesciencesreview.commarketing@lifesciencesreview.com
< Page 5 | Page 7 >